Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massaia

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemiaF Adami, A Guarini, M Pini, et al.
Haematologica|October 1, 1989
[Prognostic factors in multiple myeloma]M Boccadoro, A Bianchi, U Dianzani, et al.
Archives of Gerontology and Geriatrics. Supplement|June 30, 2001
Risk factors for dementia of Alzheimer's type: a case-control, retrospective evaluationM Massaia, A Pallavicino Di Ceva, M Bo, et al.
Haematologica|June 1, 1991
[Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications]M Boccadoro, S Battaglio, U Dianzani, et al.
Journal of Clinical Immunology|July 1, 1989
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytesL Matera, R Foa, M Massaia, et al.
Leukemia|October 24, 2003
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapyM Coscia, S Mariani, S Battaglio, et al.
Blood|September 15, 1993
Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cellsM Massaia, C Attisano, S Peola, et al.
Nephron|January 1, 1992
Immunologic characteristics of fibrillary glomerulonephritisC Rollino, D Roccatello, G Mazzucco, et al.
British Journal of Haematology|July 10, 2001
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusionS Mariani, M Coscia, J Even, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosisM Boccadoro, F Marmont, M Tribalto, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemiaF Adami, A Guarini, M Pini, et al.
Haematologica|October 1, 1989
[Prognostic factors in multiple myeloma]M Boccadoro, A Bianchi, U Dianzani, et al.
Archives of Gerontology and Geriatrics. Supplement|June 30, 2001
Risk factors for dementia of Alzheimer's type: a case-control, retrospective evaluationM Massaia, A Pallavicino Di Ceva, M Bo, et al.
Haematologica|June 1, 1991
[Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications]M Boccadoro, S Battaglio, U Dianzani, et al.
Journal of Clinical Immunology|July 1, 1989
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytesL Matera, R Foa, M Massaia, et al.
Leukemia|October 24, 2003
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapyM Coscia, S Mariani, S Battaglio, et al.
Blood|September 15, 1993
Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cellsM Massaia, C Attisano, S Peola, et al.
Nephron|January 1, 1992
Immunologic characteristics of fibrillary glomerulonephritisC Rollino, D Roccatello, G Mazzucco, et al.
British Journal of Haematology|July 10, 2001
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusionS Mariani, M Coscia, J Even, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosisM Boccadoro, F Marmont, M Tribalto, et al.
Pageof 9